Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial...
Astellas Pharma Inc and Pfizer Inc announced the amendment of the protocol for the registrational...
HedgePath Pharma Announces granting of Type-C meeting request by FDA and provides positive clinical...
HedgePath Pharmaceuticals, Inc , a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize...
KUKA Medical Robotics at the CMEF in Shanghai: robots assist surgeons dur-ing operations
KUKA is showcasing the possibilities of using sensitive robots to support doc-tors at the flagship...
AstraZeneca Imfinzi significantly reduces the risk of disease in the Phase III PACIFIC trial...
AstraZeneca and MedImmune, its global biologics research and development arm announced positive results for the...
Overcoming the challenges of clinical trial recruitment using big data technologies
The problem defined: Any prospective new drug must successfully pass a succession of three clinical...
Cell based therapy and FDA review: Partnering for success at your pre-IND meeting
Regenerative and cell-based therapies have only recently begun to deliver on the promise they have...
Recipharm opens new GMP suite for clinical trial material
Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite...
MGC Diagnostics Announces Clinical Study to Evaluate the Diagnostic Accuracy of FOT
MGC Diagnostics Corporation , a global medical technology company, today announced a new clinical study collaboration...
Inovio Ebola Vaccine Demonstrates Robust Immune Responses with Favorable Safety Profile in Expanded Clinical...
Inovio Pharmaceuticals, Inc. announced preliminary results from the expanded stage of its phase I study,...
Cytori Receives FDA Approval for Burn Clinical Trial Related to BARDA Contract
Cytori Therapeutics, Inc. announced that the U.S. FDA has approved an IDE for a pilot...
